Product Information
HALOBETASOL PROP 0.05% OINTMNT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.8428 per GM under NDC 45802013135. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 16, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802013135
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HALOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076872FDA Approved
12/16/2004
TE Code
AB
On Market Since
2/5/2009
Pharmacological Classes
Price Statistics
The NADAC for HALOBETASOL PROP 0.05% OINTMNT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 77.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8428 per GM |
|---|---|
| All-time high | $4.2931 (Feb 11, 2015) |
| All-time low | $0.6610 (Jun 17, 2026) |
| 52-week high | $0.9028 |
| 52-week low | $0.6610 |
| Median price | $2.4862 |
| Average price | $2.4016 |
| Largest weekly change | +60.8% (Nov 23, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Halobetasol Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOBETASOL PROP 0.05% OINTMNT?
The current National Average Drug Acquisition Cost (NADAC) for HALOBETASOL PROP 0.05% OINTMNT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.8428 per GM (NDC 45802013135), effective Sep 30, 2026.
How has the price of HALOBETASOL PROP 0.05% OINTMNT changed over time?
Over the history we have for it, the NADAC for HALOBETASOL PROP 0.05% OINTMNT has declined 77.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HALOBETASOL PROP 0.05% OINTMNT?
Since Nov 28, 2013, the NADAC for HALOBETASOL PROP 0.05% OINTMNT has ranged from a low of $0.6610 (Jun 17, 2026) to a high of $4.2931 (Feb 11, 2015), with a median of $2.4862 per GM.
Are there cheaper alternatives to HALOBETASOL PROP 0.05% OINTMNT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOBETASOL PROP 0.05% OINTMNT, is $0.3972 per GM — about 53% below HALOBETASOL PROP 0.05% OINTMNT.
Who manufactures HALOBETASOL PROP 0.05% OINTMNT?
HALOBETASOL PROP 0.05% OINTMNT (NDC 45802013135) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.